Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms

被引:2
|
作者
Monaco, Martina [1 ]
Trebesova, Hanna [1 ]
Grilli, Massimo [1 ,2 ]
机构
[1] Univ Genoa, Dept Pharm, Viale Cembrano 4, I-16148 Genoa, Italy
[2] Interuniv Ctr Promot 3Rs Principles Teaching & Res, I-16148 Genoa, Italy
关键词
Alzheimer's disease; muscarinic receptors; cholinergic transmission; neuroinflammation; innovative therapy; ACETYLCHOLINE-RECEPTOR; BINDING; DEFICITS; AGONIST; MEMORY; MODEL; NEUROINFLAMMATION; EXPRESSION; AROUSAL; PROTEIN;
D O I
10.3390/cimb46070407
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases on a global scale. Historically, this pathology has been linked to cholinergic transmission, and despite the scarcity of effective therapies, numerous alternative processes and targets have been proposed as potential avenues for comprehending this complex illness. Nevertheless, the fundamental pathophysiological mechanisms underpinning AD remain largely enigmatic, with a growing body of evidence advocating for the significance of muscarinic receptors in modulating the brain's capacity to adapt and generate new memories. This review summarizes the current state of the art in the field of muscarinic receptors' involvement in AD. A specific key factor was the relationship between comorbidity and the emergence of new mechanisms.
引用
收藏
页码:6820 / 6835
页数:16
相关论文
共 50 条
  • [21] Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction
    Zuo, Li-jun
    Guo, Peng
    Liu, Li
    Yu, Shu-yang
    Lian, Teng-hong
    Yu, Qiu-jin
    Hu, Yang
    Jin, Zhao
    Wang, Rui-dan
    Piao, Ying-shan
    Li, Li-xia
    Wang, Ya-jie
    Wang, Xiao-min
    Zhang, Wei
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (02) : 789 - 799
  • [22] Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimer's Disease
    Campillo, N. E.
    Paez, J. A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (05) : 539 - 559
  • [23] SIRT2 as a potential new therapeutic target for Alzheimer's disease
    Sola-Sevilla, Noemi
    Puerta, Elena
    NEURAL REGENERATION RESEARCH, 2024, 19 (01) : 124 - 131
  • [24] New roles for Fc receptors in neurodegeneration-the impact on lmmunotherapy for Alzheimer's Disease
    Fuller, James P.
    Stavenhagen, Jeffrey B.
    Teeling, Jessica L.
    FRONTIERS IN NEUROSCIENCE, 2014, 8
  • [25] C/EBPβ in Alzheimer's disease: An integrative regulator of pathological mechanisms
    Luo, Xiaoting
    Liang, Junyi
    Lei, Xue
    Sun, Fengqi
    Gong, Minghai
    Liu, Bin
    Zhou, Zhongguang
    BRAIN RESEARCH BULLETIN, 2025, 221
  • [26] New Perspectives on Alzheimer's Disease and Nutrition
    Gustafson, Deborah R.
    Morris, Martha Clare
    Scarmeas, Nikolaos
    Shah, Raj C.
    Sijben, John
    Yaffe, Kristine
    Zhu, Xiongwei
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 46 (04) : 1111 - 1127
  • [27] Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
    Liu, Zhuo-Ting
    Liu, Ming-Han
    Xiong, Yan
    Wang, Yan-Jiang
    Bu, Xian-Le
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5720 - 5739
  • [28] The utility of muscarinic agonists in the treatment of Alzheimer's disease
    Messer, WS
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (1-2) : 187 - 193
  • [29] The utility of muscarinic agonists in the treatment of alzheimer’s disease
    William S. Messer
    Journal of Molecular Neuroscience, 2002, 19 : 187 - 193
  • [30] Neuroinflammatory perspectives on the two faces of Alzheimer's disease
    Eikelenboom, P
    van Gool, WA
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (03) : 281 - 294